Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formationHide this content
Distribution Data
US Market Release
2018-03-01
CE Approval Date
2017-11-10
Registered USA Implants
442
Estimated Active USA Implants
391
Normal Battery Depletions
US Market Release
2018-03-01
CE Approval Date
2017-11-10
Estimated WW Distribution
8329
Normal Battery Depletions
Malfunctions (USA)
Therapy Function Not Compromised
1
Electrical Component
1
Therapy Function Compromised
0
Malfunctions (WW)
Therapy Function Not Compromised
1
Electrical Component
1
Therapy Function Compromised
0
EOS Indicator
From the point that the RRT is set, the
pacemaker will operate for approximately
three months for typical pacemaker
configurations during the normal
operating life.
Recommended Replacement (RRT)
Battery voltage less than 2.73V on 3
consecutive daily automatic
measurements.
